Subscribe to RSS
DOI: 10.1055/s-0040-1701226
Relationship between Sedative Antihistamines and the Duration of Febrile Seizures
Funding There is no funding to disclose.Publication History
13 September 2019
22 November 2019
Publication Date:
14 January 2020 (online)
Abstract
Some studies have shown that sedative antihistamines prolong febrile seizure duration. Although the collective evidence is still mixed, the Japanese Society of Child Neurology released guidelines in 2015 that contraindicated the use of sedative antihistamines in patients with febrile seizure. Focused on addressing limitations of previous studies, we conducted a cross-sectional study to evaluate the relationship between febrile seizure duration and the use of sedative antihistamines. Data were collected from patients who visited St. Luke's International Hospital due to febrile seizure between August 2013 and February 2016. Patients were divided into groups based on their prescribed medications: sedative antihistamine, nonsedative antihistamine, and no antihistamine. Seizure duration was the primary outcome and was examined using multivariate analyses. Of the 426 patients included, sedative antihistamines were administered to 24 patients. The median seizure duration was approximately 3 minutes in all three groups. There was no statistical difference in the bivariate (p = 0.422) or multivariate analyses (p = 0.544). Our results do not support the relationship between sedative antihistamine use and prolonged duration of febrile seizure. These results suggest that the use of antihistamines may be considered for patients with past history of febrile seizure, when appropriate.
Location of the Study
Data collection was performed at the Department of Pediatrics, St. Luke's International Hospital.
Author Contributions
A.D. was the principal investigator and designed the study, identified the subjects, and drafted the manuscript. S.T., M.Y., M.O., and I.K. conceived the study, and assisted in the design and implementation of the study. K.H., K.Y.U., Y.I. contributed to the analysis and interpretation of the data. G.Y., A.M., and H.K. provided critical revision of the manuscript for intellectual content. All authors reviewed the final draft of the manuscript and edited for content accuracy.
Ethical Approval
The study protocol was approved by the Institutional Review Board of St. Luke's International Hospital and was conducted according to the Declaration of Helsinki (approval number: 17-R106).
-
References
- 1 Johnston MV. Seizures in childhood. In: Kliegman RM, Behrman RE, Jhenson HB, Stanton BMD. , eds. Nelson Textbook of Pediatrics. Elsevier; 2008: 2457-2458
- 2 Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsia 1994; 35 (Suppl. 02) S1-S6
- 3 Nørgaard M, Ehrenstein V, Mahon BE, Nielsen GL, Rothman KJ, Sørensen HT. Febrile seizures and cognitive function in young adult life: a prevalence study in Danish conscripts. J Pediatr 2009; 155 (03) 404-409
- 4 Lewis DV, Shinnar S, Hesdorffer DC. , et al; FEBSTAT Study Team. Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study. Ann Neurol 2014; 75 (02) 178-185
- 5 Shinnar S, Bello JA, Chan S. , et al; FEBSTAT Study Team. MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study. Neurology 2012; 79 (09) 871-877
- 6 Watanabe T, Yanai K. Studies on functional roles of the histaminergic neuron system by using pharmacological agents, knockout mice and positron emission tomography. Tohoku J Exp Med 2001; 195 (04) 197-217
- 7 Ishikawa T, Takechi K, Rahman A. , et al. Influences of histamine H1 receptor antagonists on maximal electroshock seizure in infant rats. Biol Pharm Bull 2007; 30 (03) 477-480
- 8 Yokoyama H, Onodera K, Maeyama K. , et al. Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of α-fluoromethyl histidine and metoprine. Naunyn Schmiedebergs Arch Pharmacol 1992; 346 (01) 40-45
- 9 Iinuma K, Yokoyama H, Otsuki T. , et al. Histamine H1 receptors in complex partial seizures. Lancet 1993; 341 (8839): 238
- 10 Yamashita Y, Isagai T, Seki Y, Ohya T, Nagamitsu S, Matsuishi T. West syndrome associated with administration of a histamine H1 antagonist, oxatomide. Kurume Med J 2004; 51 (3-4): 273-275
- 11 Kimura T, Watanabe A, Matsuoka T. Sedating antihistamines extend the duration of febrile convulsion [in Japanese]. No To Hattatsu 2014; 46 (01) 45-46
- 12 Takano T, Sakaue Y, Sokoda T. , et al. Seizure susceptibility due to antihistamines in febrile seizures. Pediatr Neurol 2010; 42 (04) 277-279
- 13 Zolaly MA. Histamine H1 antagonists and clinical characteristics of febrile seizures. Int J Gen Med 2012; 5: 277-281
- 14 Miyata I, Saegusa H, Sakurai M. Seizure-modifying potential of histamine H1 antagonists: a clinical observation. Pediatr Int 2011; 53 (05) 706-708
- 15 Natsume J, Hamano SI, Iyoda K. , et al. New guidelines for management of febrile seizures in Japan. Brain Dev 2017; 39 (01) 2-9
- 16 Subcommittee on Febrile Seizures; American Academy of Pediatrics. Neurodiagnostic evaluation of the child with a simple febrile seizure. Pediatrics 2011; 127 (02) 389-394
- 17 Yanai K, Tashiro M. The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies. Pharmacol Ther 2007; 113 (01) 1-15
- 18 Trinka E, Cock H, Hesdorffer D. , et al. A definition and classification of status epilepticus—Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015; 56 (10) 1515-1523
- 19 R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: T Foundation for Statistical Computing; 2005. . ISBN 3–900051–07–0. Available at: http://www.R-project.org . Accessed January 11, 2016
- 20 Hesdorffer DC, Benn EK, Bagiella E. , et al; FEBSTAT Study Team. Distribution of febrile seizure duration and associations with development. Ann Neurol 2011; 70 (01) 93-100
- 21 Hjeresen DL, Diaz J. Ontogeny of susceptibility to experimental febrile seizures in rats. Dev Psychobiol 1988; 21 (03) 261-275
- 22 Yonemoto K, Okanari K, Koga H. Optimal doses of H1 antihistamines do not increase susceptibility to febrile convulsions in children. Pediatr Neurol 2018; 87: 42-47
- 23 Takasu M, Kubota T, Tsuji T, Kurahashi H, Numoto S, Okumura A. The effects of antihistamines on the semiology of febrile seizures. Brain Dev 2019; 41 (01) 72-76
- 24 Tsujii T, Masuda S, Yamamoto E. , et al. Effects of sedative and nonsedative antihistamines on prefrontal activity during verbal fluency task in young children: a near-infrared spectroscopy (NIRS) study. Psychopharmacology (Berl) 2009; 207 (01) 127-132
- 25 Maytal J, Shinnar S. Febrile status epilepticus. Pediatrics 1990; 86 (04) 611-616